Other
Jun 2024Reuters reported that Seed's owners were exploring a potential sale valuing the company at more than $1 billion. The report described an exploration process, not a completed transaction.
SourceCompany research
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Overview
Seed Health is a privately held microbiome-science company developing clinically studied probiotics, synbiotics, live biotherapeutics, computational biology tools, and environmental microbial solutions. Its consumer products are commercialized under the Seed® brand, while environmental work is conducted through SeedLabs.
Primary product
DS-01® Daily Synbiotic, a probiotic-plus-prebiotic daily supplement. Seed also sells pediatric, vaginal-health, multivitamin, energy/focus, and sleep products.
Founded
2016
Headquarters
Venice, California, United States
Team size
100-150
Work style
Remote
Industry
Biotechnology
Sub-industry
Microbiome therapeutics, probiotics, consumer health, and nutritional supplements
Offices
Venice, California, United States
Los Angeles, California, United States
New York City, New York, United States
Australia
Business model
Direct-to-consumer subscriptions
E-commerce
Omnichannel retail
Amazon marketplace
Corporate and practitioner distribution
Biotechnology research and product development
Funding
Stage
Series A / profitable growth company
Total raised
$43.8M
Latest round
Series A · Apr 2021
Latest amount
$40M
Apr 2021 · The Craftory
Mar 2019
Jun 2017
People & investors
Leadership
Chief Executive Officer
Chairperson of the Board; Co-Founder
Raja Dhir
Co-Founder; Board Director
Dirk Gevers
Chief Scientific Officer
Zain Kassam, M.D., M.P.H.
Chief Medical Officer
Brian Helman
Chief Financial Officer
Chief Technology Officer
Vice President of Engineering
Anisha Raghavan
Chief Marketing Officer
Work & culture
Seed presents itself as science-first, impact-oriented, collaborative, and human-centered, with emphasis on translating microbiome research into products and environmental applications. Job postings describe a remote-first culture emphasizing autonomy, clarity, inclusion, and measurable impact.
Work style
Remote
Visa sponsorship
Limited
Compensation
Public US job postings show base salary ranges commonly around $160,000-$230,000 for senior management, product, marketing, and technology positions, and up to approximately $250,000-$275,000 for some senior roles, generally plus equity and benefits. Some 2025 labor-condition-application records indicate prior H-1B filings, but current job postings have stated that particular remote US roles were not eligible for visa sponsorship.
Benefits
Medical, dental, and vision insurance
Employer-supported HSA
Life, AD&D, and long-term disability insurance
Mental-wellness benefits and Employee Assistance Program
12 free therapy sessions annually for employees and eligible dependents
401(k) with match and immediate vesting
18 weeks of fully paid parental leave
15 vacation days
7 sick/safe days
2 personal days
10 company Recharge Days
15 paid company holidays
Pet insurance
Learning and development support
$750 remote-work setup stipend for eligible roles/employees recruited through posted positions explicitly offering it
Product & market
Pricing
Premium subscription and omnichannel product sales. DS-01 is advertised on Seed's website at $49.99 per month, with additional products and retail one-time purchase options. Retail and marketplace prices may differ from direct subscription pricing.
Differentiators
- —Broad-spectrum synbiotic formulations combining probiotic strains with prebiotics
- —Clinical and strain-level research orientation, including company-sponsored clinical studies
- —ViaCap dual-capsule delivery system designed to protect ingredients through the stomach
- —Proprietary microbiome data and computational biology capabilities
- —CODA platform using large-scale host-microbiome and multi-omics data for discovery
- —End-to-end model spanning research, product development, commercialization, and environmental microbial innovation
- —Science-led branding and education compared with many mass-market supplement competitors
- —Sustainability-oriented refill packaging and SeedLabs environmental programs
Technology
Computational biology
Microbial genomics
Ultra-deep sequencing
AI and machine learning
Metabolomics
Multi-omics analysis
CODA computational biology platform
React
TypeScript
Node.js
Python
Django
Shopify
Stripe
Recharge
Recurly
NetSuite
Snowflake
dbt
Fivetran/ data integration tools
Customers
More than one million consumers, according to Seed's 2024 Target announcement
Direct-to-consumer subscribers
Amazon customers
Target shoppers nationwide
Sprouts Farmers Market shoppers in approximately 450 stores across 24 states
Erewhon customers
Healthcare practitioners and corporate-wellness channels
Competitors
Ritual
Pendulum Therapeutics
Culturelle
Align
Visbiome/VSL#3
Garden of Life
Flore/Sun Genomics
AG1/Athletic Greens
Viome
Vedanta Biosciences
Scale & contact
Estimated revenue
Approximately $100 million-$250 million annually. Reuters reported approximately $140 million in 2023 revenue and projected approximately $200 million for 2024; WWD later reported that sources close to the company said revenue had exceeded $200 million. These are media estimates rather than audited public financial statements.
Estimated monthly visits
1.2M
Traffic estimate as of Jun 2026
Signals & risks
Other
Apr 2025Leadership transitioned from co-founders Ara Katz and Raja Dhir as co-CEOs to Cathrin Bowtell as CEO; Katz became board chair and Dhir remained an active board director. This appears to be a planned succession rather than a distress event.
SourceAcquisition
Jan 2021Seed Health announced acquisitions involving Auggi and Atmo Biosciences' ingestible gas-sensor technology. Public materials do not establish subsequent operating status or financial terms.
SourceOther
Apr 2024Seed launched CODA, an AI-enabled computational biology platform, representing a substantial allocation of company resources toward longer-term discovery and pipeline development.
SourceLatest news
Seed Health / PR Newswire · May 2025
Seed presented randomized, placebo-controlled clinical data reporting increased production of urolithin A and butyrate, along with reduced C-reactive protein, among healthy adults using DS-01.
Seed Health / PR Newswire · Sep 2024
Seed announced nationwide Target distribution for DS-01 and PDS-08, plus the Target-exclusive DS-01 14 Day Gut Reset, marking its first major mass-retail partnership.
Reuters · Jun 2024
Reuters reported that Seed's owners were exploring a potential sale at a valuation above $1 billion and cited estimated revenue of approximately $200 million for 2024.
CNBC · Apr 2024
CNBC covered Seed's profitability, its consumer subscription engine, and the launch of CODA, an AI-powered computational biology platform targeting areas including metabolic health, brain health, longevity, and menopause.
Seed Health / PR Newswire · Apr 2024
Seed announced CODA, using microbial genomics, network analysis, AI/ML, and approximately 200 TB of Human Phenotype Project data to support discovery of precision probiotics and microbiome interventions.
Jobs and careers at Seed Health
3 jobs at Seed Health
Senior Manager, Product Marketing
Remote
PMM (Product Marketing)
Remote
1mo ago
Remote
Full-time
Senior Product Manager
Remote
Product
Remote
1mo ago
Remote
Full-time
Senior ERP Manager
Remote
Technology
Remote
1mo ago
Remote
Full-time